Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

UroGen Pharma to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024


UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will report second quarter 2024 financial results on Tuesday, August 13, 2024, prior to the open of the stock market. The announcement will be followed by a live audio webcast and conference call at 10:00 AM Eastern Time.

A live public webcast of the earnings conference call can be accessed on UroGen's Investor Relations website. Following the live webcast, a replay will be available on the site for approximately 30 days.

About UroGen Pharma Ltd.

UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel® reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. Our first product to treat low-grade upper tract urothelial cancer and investigational treatment UGN-102 (mitomycin) for intravesical solution for patients with low-grade non-muscle invasive bladder cancer are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel.


These press releases may also interest you

at 05:45
Levi & Korsinsky, LLP notifies investors in STMicroelectronics N.V. ("STMicroelectronics" or the "Company") of a class action securities lawsuit....

at 05:45
Levi & Korsinsky, LLP notifies investors in Spire Global, Inc. ("Spire Global" or the "Company") of a class action securities lawsuit....

at 05:33
Beko, a global...

at 05:30
In a groundbreaking move to bolster America's clean energy future, the U.S. Department of Energy's (DOE) Office of Manufacturing and Energy Supply Chains and the state of Michigan's Competitiveness Fund have selected Mitra Chem, a leading innovator...

at 05:07
The fifth Finance in Common (FiCS) annual summit will take place on Feb. 26-28, 2025, co-hosted by the Development Bank of Southern Africa (DBSA) and the Asian Infrastructure Investment Bank (AIIB) in Cape Town, Republic of South Africa, with the...

at 04:30
Metasphere Labs Inc. ("Metasphere" or the "Company") (FRA: H1N) , a leader in metaverse and Web3 strategies, is pleased to announce the successful completion of the development of Pure Sky Registry LLC's ("Pure Sky") blockchain-based carbon credit...



News published on and distributed by: